FindTrial
Sign In

UCB-NK cells

BIOLOGICAL2 trials

Sponsors

Radboud University Medical Center

Conditions

Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, Relapsed, AdultRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma

Phase 1

Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients
CompletedNCT03539406
Radboud University Medical CenterRecurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma
Start: 2019-06-04End: 2023-09-01Updated: 2024-08-09
Natural Killer-cell Therapy for Acute Myeloid Leukemia
TerminatedNCT04347616
Radboud University Medical CenterAcute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult
Start: 2020-12-03End: 2026-01-30Updated: 2026-03-16

Related Papers

Intraperitoneal infusion of stem cell-derived natural killer cells in recurrent epithelial ovarian cancer patients: Results of the phase 1 INTRO-01 trial.
2025-11-241 citations
181 INTRO-study: intraperitoneal infusion of allogeneic stem-cell derived natural killer cells in recurrent ovarian carcinoma patients
2024-03-01
Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia
Cancer Immunology Immunotherapy2023-07-2117 citations